SCHEMBL14933629

SCHEMBL14933629

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1noc2ccc(-c3cc(Cl)ccc3O)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.42
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 2/20 0.38
SCN9A Q15858 6/20 0.38
PDPK1 O15530 1/20 0.35
MEN1 O00255 3/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
EPHX2 P34913 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPT P10636 2/20 0.32
ALOX15 P16050 2/20 0.32
MAPK1 P28482 2/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SCN5A Q14524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16021936 0.88 HDAC1 (0.36) FAAHKMT2AALDH1A1SCN9APDPK1
SCHEMBL16021942 0.86 FAAH (0.35) FAAHKMT2AALDH1A1SCN9APDPK1
SCHEMBL14920522 0.83 FAAH (0.40) FAAHKMT2AALDH1A1SCN9AMEN1
SCHEMBL14933653 0.80 PIM1 (0.38) KMT2AALDH1A1PDPK1MEN1CSNK2A1
SCHEMBL14933657 0.80 ESR1 (0.42) FAAHKMT2AALDH1A1PDPK1MEN1
SCHEMBL16011441 0.78 MAP2K4 (0.39) PDPK1MAPT
SCHEMBL14919956 0.78 MAPT (0.32) KMT2APDPK1MEN1MAPTALOX15
SCHEMBL1759441 0.77 MAPT (0.46) FAAHMAPTLMNA
SCHEMBL16022001 0.77 HDAC3 (0.40) SCN9APDPK1
SCHEMBL8265372 0.76 SOS1 (0.39) FAAHKMT2AALDH1A1PDPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773641-B1 BIARYL ETHER SULFONAMIDES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2017-09-27 EP disclosed
WO-2013064984-A1 BIARYL ETHER SULFONAMIDES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2013-05-10 WO disclosed